keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Z-Phe-Ala-diazomethylketone directly binds to Aβ42 monomers and small oligomers, effectively inhibiting the formation of Aβ42 dodecamers and preventing Aβ42 fibrillogenesis in solution. This compound holds potential for research into neurodegenerative disorders [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Z-Phe-Ala-diazomethylketone directly binds to Aβ42 monomers and small oligomers, effectively inhibiting the formation of Aβ42 dodecamers and preventing Aβ42 fibrillogenesis in solution. This compound holds potential for research into neurodegenerative disorders [1]. |
Synonyms | PADK |
Molecular Weight | 394.42 |
Formula | C21H22N4O4 |
CAS No. | 71732-53-1 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Z-Phe-Ala-diazomethylketone 71732-53-1 PADK inhibitor inhibit